Late last week the US Food and Drug Administration announced that clinicians should avoid using certain bone graft substitutes in patients under the age of 18 because they can carry serious injury risk. The specific bone graft substitutes in question contain recombinant proteins or synthetic peptides that mimic the bone’s natural growth. When paired with what’s known […]